Apyx Medical Corp. (APYX) Tops Q4 EPS by 4c ; Offers Guidance

Apyx Medical Corp. (NASDAQ: APYX) reported Q4 EPS of ($0.12), $0.04 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $14.2 million versus the consensus estimate of $13.02 million.

GUIDANCE:

Apyx Medical Corp. sees FY2025 revenue of $47.6-49 million, versus the consensus of $47.28 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.

You May Also Be Interested In

• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• Qualcomm (QCOM) PT Raised to $195 at BofA Securities
• JPMorgan Starts Central Depository Services India Ltd (CDSL:IN) at Underweight